Examkin

Question

Difficulty: MediumGynecologic Oncology

Accompanied by her sister, a 6868-year-old female comes to the outpatient clinic to establish care. While reviewing her symptoms, she casually notes seeing a pinkish discharge on her toilet tissue twice over the past month. She denies pelvic pain, weight loss, or dysuria. She reached natural menopause 1616 years ago and had no vaginal bleeding until this recent episode. Her medical history includes hypertension, type 2 diabetes mellitus, and osteoarthritis. Current medications include lisinopril and metformin. Vital signs are within normal limits, and her body mass index is 34 kg/m234\text{ kg/m}^2. Pelvic examination reveals atrophic external genitalia and a pale vaginal vault with no gross lesions. A bedside transvaginal ultrasound reveals an endometrial thickness of 7 mm7\text{ mm}. Which of the following is the most appropriate next step in the management of this patient?

  1. A
    Prescription of topical vaginal estrogen
  2. B
    Routine cervical cytology and human papillomavirus testing
  3. Endometrial biopsyAnswer
  4. D
    Magnetic resonance imaging of the pelvis
  5. E
    Reassurance and repeat transvaginal ultrasound in 6 months

Answer

Endometrial biopsy
The correct answer is to perform an endometrial biopsy. In a postmenopausal patient, any vaginal bleeding is considered abnormal and must be aggressively evaluated to rule out endometrial carcinoma. The standard initial evaluation utilizes a transvaginal ultrasound. If the endometrial thickness is greater than 4 mm4\text{ mm}, it is highly suspicious for endometrial hyperplasia or cancer, and tissue sampling via endometrial biopsy is strictly indicated. Although this patient exhibits signs of vaginal atrophy (which is a common, benign cause of spotting), her obesity (BMI of 34 kg/m234\text{ kg/m}^2) and diabetes are significant risk factors for unopposed estrogen exposure and subsequent endometrial cancer. Thus, her thickened endometrium (7 mm7\text{ mm}) mandates prompt histologic evaluation.

Step-by-Step Solution

1
Identify the primary clinical presentation.
A postmenopausal woman presents with new-onset vaginal spotting (postmenopausal bleeding) alongside risk factors including obesity and type 2 diabetes.
Recognizing postmenopausal bleeding is critical as it is the most common presenting symptom of endometrial carcinoma.
2
Evaluate the results of the initial diagnostic workup.
Transvaginal ultrasound demonstrates an endometrial stripe thickness of 7 mm.
The initial step in evaluating postmenopausal bleeding is often a transvaginal ultrasound to assess the endometrial thickness. A stripe of 4 mm or less has a high negative predictive value for cancer.
3
Determine the required definitive diagnostic procedure.
The patient requires an endometrial biopsy.
Because her endometrial thickness is greater than 4 mm, she is at significant risk for endometrial hyperplasia or malignancy, mandating histologic tissue sampling.

Key Concept

Postmenopausal bleeding with an endometrial stripe > 4 mm requires an endometrial biopsy to rule out endometrial hyperplasia or carcinoma.
Rate this question

Topics

Gynecologic Oncology

More questions from this topic